GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,254 | -31.5% | 7,454,703 | -0.5% | 0.00% | -33.3% |
| Q2 2023 | $41,219 | +25.4% | 7,494,184 | -2.0% | 0.01% | +20.0% |
| Q1 2023 | $32,871 | +15.2% | 7,644,195 | +5.3% | 0.01% | 0.0% |
| Q4 2022 | $28,536 | -99.9% | 7,261,046 | -1.8% | 0.01% | -16.7% |
| Q3 2022 | $39,272,000 | -33.0% | 7,395,573 | -17.2% | 0.01% | -14.3% |
| Q2 2022 | $58,591,000 | -8.9% | 8,931,613 | +1.9% | 0.01% | +16.7% |
| Q1 2022 | $64,325,000 | +5.1% | 8,763,691 | +1.3% | 0.01% | 0.0% |
| Q4 2021 | $61,222,000 | -71.7% | 8,647,121 | +0.2% | 0.01% | -70.0% |
| Q3 2021 | $216,309,000 | +9.2% | 8,628,216 | +17.2% | 0.02% | +11.1% |
| Q2 2021 | $198,068,000 | +7.3% | 7,363,115 | +13.5% | 0.02% | 0.0% |
| Q1 2021 | $184,550,000 | +48.1% | 6,484,544 | +47.6% | 0.02% | +38.5% |
| Q4 2020 | $124,575,000 | -3.3% | 4,394,184 | +1.7% | 0.01% | -13.3% |
| Q3 2020 | $128,866,000 | +52.3% | 4,320,962 | +3.3% | 0.02% | +36.4% |
| Q2 2020 | $84,615,000 | – | 4,181,178 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 857,939 | $26,519,000 | 5.98% |
| Casdin Capital, LLC | 1,611,214 | $49,803,000 | 2.23% |
| Artal Group S.A. | 2,814,191 | $86,987,000 | 2.11% |
| HARVARD MANAGEMENT CO INC | 506,273 | $15,649,000 | 0.86% |
| Bellevue Group AG | 1,880,000 | $58,111,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 961,215 | $29,711,000 | 0.72% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,120,625 | $65,549,000 | 0.45% |
| SECTORAL ASSET MANAGEMENT INC | 35,000 | $1,082,000 | 0.09% |
| MIRABELLA FINANCIAL SERVICES LLP | 8,886 | $275,000 | 0.04% |
| VICTORY CAPITAL MANAGEMENT INC | 866,997 | $26,798,000 | 0.03% |